Medical College of Georgia, Augusta, Georgia, USA
Founded in 1828, the Medical College of Georgia ("MCG") is the 13th-oldest continuously operating medical school in the United States and the third-oldest in the Southeastern United States.
MCG, Georgia’s health sciences university, has more than 2,400 students in five schools: Medicine, Allied Health Sciences, Dentistry, Graduate Studies and Nursing. Students come from most of Georgia’s 159 counties. Students from other states and foreign countries comprise approximately 2 percent of MCG’s student body.
MCG offers modern classrooms and laboratories, the 540-bed MCG Medical Center, the Children’s Medical Center, extensive outpatient clinics, residence halls, a student center, a wellness center and an outstanding medical education library with more than 164,984 books and bound journals and approximately 4,000 periodicals.
With approximately 5,000 faculty, staff and residents, MCG is one of the largest employers in the Augusta area. The University System of Georgia reports that during the 2007 fiscal year, an additional 3,800 jobs resulted from spending related to the institution, and its overall economic impact on the area approached nearly $1 billion.
The mission of the Medical College of Georgia is to discover, disseminate, and apply knowledge to improve health and reduce the burden of illness on society.
In realizing its mission, the Medical College of Georgia is committed to serving the people of Georgia, the nation, and the world by:
- Preparing the health professional workforce of the future
- Conducting research through programs that create, disseminate, and apply new knowledge relevant to human health
- Providing exceptional, innovative, patient-centered health care services
- Contributing to the economic development and well being of the State of Georgia through integrated programs in education, research and clinical care.
Henogen Biomanufacturing, SA, Gosselies, Belgium
ImmunoScience is in the process of finalizing an alliance with Henogen Biomanufacturing of Gosselies, Belgium. Henogen's GMP facility is designed for the biopharmaceutical production and purification of macromolecules and viral vectors for clinical studies. The facility is fully compliant with the Commission of the European Communities Directives 2003/94/CE which establish the principles and guidelines for the Good Manufacturing Practices of medicinal products for human and veterinary use.
The GMP facility has an area of 430 m2 and consists mainly of BL2 and BL3 rooms. It consists of two separate wings, one of which is dedicated to the preparation of macromolecules, the other to the preparation of viral vectors. Both wing entrance corridors are accessed through the entrance gowning room and are separated by an airlock in overpressure.
With 20 years of experience in industrial processes, Henogen, a spin-off of the ULB (Free University of Brussels), controls all the steps of recombinant macromolecule and viral vector manufacturing.
Henogen has strategic alliances with the Pasteur Institute, Glaxo Smith Kline Biologicals, Biopole, Wyeth and Immutep.
Joint Clinical Research Centre, Kampala, Uganda
The Joint Clinical Research Center (JCRC) was founded in 1991 to serve as a national AIDS Research Centre. JCRC is Uganda’s pioneer Centre of Excellence for AIDS care, treatment, research, and training that was founded at the height of the AIDS crisis in Uganda by the government as a strategic partnership between the Ministry of Health, Ministry of Education and the Ministry of Defence. JCRC is an autonomous non-profit limited liability company without share capital, governed by a Board of Trustees.
JCRC pioneered the use of antiretroviral drugs (ARVs) in Uganda in 1992, and is the largest provider of ARVs in sub-Saharan Africa. The JCRC has since expanded, and is currently the largest Antiretroviral (ART) provider in the country and one of the biggest Presidential Emergency Plan for AIDS Relief (PEPFAR) supported ART centers in Africa. JCRC has the biggest network of reference laboratories providing services to other centers providing ARVs in the country and the Great Lakes region with capacity to carry out quality tests required for safe and effective Antiretroviral therapy monitoring and detection of resistance to ARVs.
The principal purpose of the JCRC is to conduct HIV/AIDS related research; provide care and treatment to HIV/AIDS patients and to build a national capacity for HIV/AIDS management.
Noguchi Memorial Institute for Medical Research, Accra, Ghana
Founded in 1979, The Noguchi Memorial Institute for Medical Research (NMIMR) has become one of the premier biomedical research institutions on the African continent. Building on a century of biomedical research in Ghana, the Institute collaborates with African, Asian, European, and North American partners on numerous projects, large and small, in medicine and public health.
Growth at NMIMR continues in its several departments: Animal Experimentation, Bacteriology, Clinical Pathology, Electron Microscopy and Histology, Epidemiology, Immunology, Nutrition, Parasitology, and Virology. NMIMR houses national and international centres and laboratories such as the National Influenza Centre, a WHO accredited polio laboratory, the Lymphatic Filariasis Support Centre for Africa (LFSCA),and the West African Centre for International Parasite Control (WACIPAC). The Institute also has an Information Technology infrastructure and library to support its activities.
The original research targets involved infectious diseases and nutrition such as malaria, other parasitic diseases, diseases related to poor nutrition, and new methodologies. The Institute’s writ expanded recently to include non-infectious diseases such as diabetes mellitus, sickle cell, and cancer.
NMIMR collaborates in various capacities with other universities, national programmes, non-governmental groups, and international initiatives. The Institute hosts the West African Centre for Parasite Control (WACIPAC) and the Lymphatic Filariasis Support Centre for Africa (LFSCA) . It is mainly through such collaborations that the Institute has been able to implement and support solutions to national, regional, and global health challenges. Various Departments and researchers have participated in clinical trials, and the new Clinical Trials Facility opened in 2004.
The Institute has upgraded its facilities and staff qualifications to enable it to operate reference laboratories and collections at the national and West African regional levels. This capacity will undergo expansion in 2008-2009.
BioEgypt is an Egypt-based health care company operating in the Middle East Region in the field of disease prevention and cure. Driven by its customers' unmet needs, it is seeking solutions to deliver products deficient in the market contributing to health and improving the quality of human life. Hence, it is holding the agencies of some multinational companies and distributing their products in the region, taking advantage of our distinguished storage and distribution capabilities and highly experienced team for whole sale distribution and marketing.
Its mission is to provide health care products that add quality to human life, satisfy its customers' unmet needs and contribute to their well-being. These products include biologicals, pharmaceuticals and biotech products, in addition to health care devices, healthy food and other non-pharma products.